Baseline glucose and left ventricular remodeling after acute myocardial infarction

Journal of Diabetes and its Complications

Volumn 21, Issue 5, 2007, Pages 294-299

  Nicolau, José C ^a   Maia, Lilia N ^b   Vitola, João V ^c   Mahaffey, Kenneth W ^d   Machado, Maurício N ^b   Ramires, José A F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Sao Jose do Rio Preto Medical School   (Brazil)

^c Federal University   (Brazil)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Hyperglycemia; Left ventricular remodeling; Myocardial infarction; Myocardial reperfusion

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLYCERYL TRINITRATE; LOSARTAN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; ST SEGMENT ELEVATION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; ELECTROENCEPHALOGRAPHY; ENALAPRIL; FEMALE; HUMANS; LOSARTAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548297730     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.01.003     Document Type: Article

References (40)

1. Angeja B.G., de Lemos J., Murphy S.A., Marble S.J., Antman E.M., Cannon C.P., et al. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. American Heart Journal 144 (2002) 649-656
2. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. Journal of the American Medical Association 287 (2002) 2570-2581
3. Bellodi G., Manicardi V., Malavasi V., Veneri L., Bernini G., Bossini P., et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. American Journal of Cardiology 64 (1989) 885-888
4. Berger A.K., Breall J.A., Gersh B.J., Johnson A.E., Oetgen W.J., Marciniak T.A., et al. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project). American Journal of Cardiology 87 (2001) 272-277
5. Biondi-Zoccai G.G., Abbate A., Liuzzo G., and Biasucci L.M. Atherothrombosis, inflammation, and diabetes. Journal of the American College of Cardiology 41 (2003) 1071-1077
6. Bolognese L., Carrabba N., Santoro G.M., Valenti R., Buonamici P., and Antoniucci D. Angiographic findings, time course of regional and global left ventricular function, and clinical outcome in diabetic patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty. American Journal of Cardiology 91 (2003) 544-549
7. Caldas M.A., Tsutsui J.M., Kowatsch I., Andrade J.L., Nicolau J.C., Ramires J.F., et al. Value of myocardial contrast echocardiography for predicting left ventricular remodeling and segmental functional recovery after anterior wall acute myocardial infarction. Journal of the American Society of Echocardiography 17 (2004) 923-932
8. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 355 (2000) 773-778
9. Chyun D., Obata J., Kling J., and Tocchi C. In-hospital mortality after acute myocardial infarction in patients with diabetes mellitus. American Journal of Critical Care 9 (2000) 168-179
10. de Lemos J.A., Antman E.M., Giugliano R.P., McCabe C.H., Murphy S.A., Van de Werf F., et al. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. American Journal of Cardiology 85 (2000) 299-304
11. Donnan P.T., Boyle D.I., Broomhall J., Hunter K., MacDonald T.M., Newton R.W., et al. Prognosis following first acute myocardial infarction in type 2 diabetes: A comparative population study. Diabetic Medicine 19 (2002) 448-455
12. Foo K., Cooper J., Deaner A., Knight C., Suliman A., Ranjadayalan K., et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89 (2003) 512-516
13. Gresele P., Guglielmini G., De Angelis M., Ciferri S., Ciofetta M., Falcinelli E., et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. Journal of the American College of Cardiology 41 (2003) 1013-1020
14. Harjai K.J., Stone G.W., Boura J., Mattos L., Chandra H., Cox D., et al. Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction. American Journal of Cardiology 91 (2003) 1041-1045
15. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nishioka K., et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. Journal of the American College of Cardiology 38 (2001) 1007-1011
16. Ishihara M., Sato H., Kawagoe T., Shimatani Y., Kurisu S., Nishioka K., et al. Impact of diabetes mellitus on long term survival after acute myocardial infarction in patients with single vessel disease. Heart 86 (2001) 133-138
17. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. Journal of the American College of Cardiology 41 (2003) 1-7
18. Klamann A., Sarfert P., Launhardt V., Schulte G., Schmiegel W.H., and Nauck M.A. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide). European Heart Journal 21 (2000) 220-229
19. Maia L.N., Nicolau J.C., Vitola J.V., Santos M., Brandi J.M., Joaquim M.R., et al. Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction. American Heart Journal 145 (2003) E21
20. Malmberg K., Norhammar A., Wedel H., and Ryden L. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99 (1999) 2626-2632
21. Malmberg K., and Ryden L. Myocardial infarction in patients with diabetes mellitus. European Heart Journal 9 (1988) 259-264
22. Mauri F., Maggioni A.P., Franzosi M.G., de Vita C., Santoro E., Santoro L., et al. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis. Journal of the American College of Cardiology 24 (1994) 600-607
23. Mukamal K.J., Nesto R.W., Cohen M.C., Muller J.E., Maclure M., Sherwood J.B., et al. Impact of diabetes on long-term survival after acute myocardial infarction: Comparability of risk with prior myocardial infarction. Diabetes Care 24 (2001) 1422-1427
24. Nicolau J.C., Maia L.N., Vitola J., Vaz V.D., Machado M.N., Godoy M.F., et al. ST-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction. American Journal of Cardiology 91 (2003) 451-453
25. Nicolau J.C., Serrano Jr. C.V., Garzon S.A., and Ramires J.A. Prognosis of acute myocardial infarction in the thrombolytic era: Medical evaluation is still valuable. European Journal of Heart Failure 3 (2001) 569-576
26. Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendic S., Ryden L., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 359 (2002) 2140-2144
27. Norhammar A.M., Ryden L., and Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 22 (1999) 1827-1831
28. O'Sullivan J.J., Conroy R.M., Robinson K., Hickey N., and Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 14 (1991) 758-760
29. Oliver M.F., and Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343 (1994) 155-158
30. Prasad A., Stone G.W., Stuckey T.D., Costantini C.O., Zimetbaum P.J., McLaughlin M., et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. Journal of the American College of Cardiology 45 (2005) 508-514
31. Schroder R., Dissmann R., Bruggemann T., Wegscheider K., Linderer T., Tebbe U., et al. Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction. Journal of the American College of Cardiology 24 (1994) 384-391
32. Schroder R., Wegscheider K., Schroder K., Dissmann R., and Meyer-Sabellek W. Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. Journal of the American College of Cardiology 26 (1995) 1657-1664
33. Shindler D.M., Palmeri S.T., Antonelli T.A., Sleeper L.A., Boland J., Cocke T.P., et al. Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: A report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. Journal of the American College of Cardiology 36 (2000) 1097-1103
34. Stubbs P.J., Laycock J., Aghband-Zadeh J., Carter G., and Noble M.I. Circulating stress hormone and insulin concentrations in acute coronary syndromes: Identification of insulin resistance on admission. Clinical Science (London) 96 (1999) 589-595
35. Suleiman M., Hammerman H., Boulos M., Kapeliovich M.R., Suleiman A., Agmon Y., et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: A prospective study. Circulation 111 (2005) 754-760
36. Timmer J.R., Ottervanger J.P., de Boer M.J., Dambrink J.H., Hoorntje J.C., Gosselink A.T., et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 45 (2005) 999-1002
37. Timmer J.R., van der Horst H.I., Ottervanger J.P., Henriques J.P., Hoorntje J.C., de Boer M.J., et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. American Heart Journal 148 (2004) 399-404
38. Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., and Cox J.L. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. Journal of the American College of Cardiology 40 (2002) 1748-1754
39. Zhang J., Ren S., Sun D., and Shen G.X. Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 18 (1998) 1140-1148
40. Zuanetti G., Latini R., Maggioni A.P., Santoro L., and Franzosi M.G. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. Journal of the American College of Cardiology 22 (1993) 1788-1794